DIH Holding US Q4 2025 Earnings Results & Report

DIH Holding US EPS Results

• Actual EPS: -$1.44
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

DIH Holding US Revenue Results

• Actual Revenue: $12.65 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

DIH Holding US (OTCMKTS:DHAI) develops and provides robotic, digital and immersive rehabilitation technologies for hospitals, outpatient clinics, research institutions and other healthcare providers. Its solutions are designed to support the assessment and treatment of patients recovering from neurological, orthopedic and movement-related conditions, as well as broader human-performance and gait-analysis applications.

The company’s product portfolio includes robotic-assisted therapy systems, body-weight-support and gait-training technologies, virtual-reality rehabilitation tools, and motion-analysis platforms. Its offerings include products associated with the Hocoma and Motek businesses, such as the Lokomat, Armeo, Andago, C-Mill, CAREN and GRAIL systems. These platforms combine robotics, sensors, software and data analysis to help clinicians deliver consistent therapy and measure patient progress.

DIH serves healthcare and research organizations internationally through a global commercial and service network. The company was formed around the combination of Hocoma, a Swiss rehabilitation-technology company, and Motek, a Netherlands-based provider of biomechanics and movement-analysis systems. Publicly available information does not provide sufficient verified detail about the company’s current leadership structure to include it reliably.